Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D3026
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 264 $157,707 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $157,707 Current and potential, with all options
- Last date to order 9% complete
- IDV ceiling <1% used
- $9,999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Indefinite Delivery Contract (IDC) SPE2DR25D3026, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, is a $9.99 billion single-award contract to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract encompasses a 30-month base period with three 30-month option periods, running through December 2036. As the prime vendor, Amerisourcebergen will be responsible for furnishing brand-name, generic, and specialty medications, as well as medical devices, syringes, vaccines, and other critical medical commodities across multiple therapeutic areas. This IDC serves as the primary vehicle for DLA Troop Support to obtain pharmaceutical and medical support for the Department of Defense, U.S. Coast Guard, and other designated government agencies and healthcare programs. The contract was competitively awarded without any set-aside requirements, demonstrating Amerisourcebergen's qualifications and capabilities to meet the government's comprehensive pharmaceutical and medical supply needs worldwide.
The IDC was derived from a broader $30.3 billion solicitation issued by DLA Troop Support to establish the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts. The intent is to have at least three different contractors awarded across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet regions, ensuring resiliency and access to vital pharmaceuticals during contingencies or natural disasters. Both primary and backup suppliers will provide separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally. The contract will be awarded on a Lowest Price Technically Acceptable (LPTA) basis, with the option to use a reverse auction to obtain the best possible distribution fees.
Task orders
Show 40 more
Latest 50 of 264 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D3026?
SPE2DR25D3026 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D3026 worth?
Orders under SPE2DR25D3026 have obligated $157,707. SPE2DR25D3026's own ceiling is $9,999,999,999.
How many orders have been placed under contract SPE2DR25D3026?
264 orders have been placed under SPE2DR25D3026, the latest on July 31, 2026.
Who can order from contract SPE2DR25D3026?
SPE2DR25D3026 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D3026 competed?
The extent of competition for SPE2DR25D3026 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV